Microglia: Small Cells, Big Impact - From Rare Genetic Disorders to New Therapeutic Opportunities

Dates and Times

Start: 9/11/2026 8:00 AM
End: 9/11/2026 9:00 AM

Objectives

1. Understand how advances in microglial biology have reshaped concepts of neurological disease.
2. Describe lessons from Krabbe disease and Aicardi-Goutières syndrome that establish microglia as drivers of human disease.
3. Discuss how these discoveries are enabling a new generation of microglia-directed therapies

Speakers

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.